PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
+10%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$59.7M
AUM Growth
+$59.7M
(-9.6%)
Cap. Flow
-$5.57M
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
41.08%
Holding
87
New
22
Increased
19
Reduced
18
Closed
22
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$1.79M |
| 2 |
Amazon
AMZN
|
$1.66M |
| 3 |
Charles Schwab
SCHW
|
$1.53M |
| 4 |
Alibaba
BABA
|
$1.43M |
| 5 |
Lam Research
LRCX
|
$1.07M |
Top Sells
| 1 |
Pfizer
PFE
|
$2.87M |
| 2 |
UnitedHealth
UNH
|
$2.83M |
| 3 |
HCA Healthcare
HCA
|
$2.45M |
| 4 |
Gilead Sciences
GILD
|
$2.19M |
| 5 |
Eli Lilly
LLY
|
$1.84M |
Sector Composition
| 1 | Healthcare | 52.15% |
| 2 | Technology | 8.57% |
| 3 | Industrials | 7.58% |
| 4 | Financials | 7.48% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $3.97M | 6.5% |
46,558
+4,765
| +11% | +$406K |
|
2
Bristol-Myers Squibb
BMY
$96B
| $3.37M | 5.52% |
48,922
+14,279
| +41% | +$982K |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $3.05M | 5.01% |
9,769
-2,016
| -17% | -$630K |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $2.49M | 4.09% |
37,993
+7,801
| +26% | +$512K |
|
5
Palo Alto Networks
PANW
$127B
| $2.42M | 3.96% |
13,719
+4,809
| +54% | +$847K |
|
6
AerCap
AER
$22B
| $2.11M | 3.46% |
48,829
+14,266
| +41% | +$616K |
|
7
Edwards Lifesciences
EW
$47.8B
| $1.86M | 3.04% |
23,494
+8,292
| +55% | +$655K |
|
|
MDCO
8
DELISTED
Medicines Co
MDCO
| $1.81M | 2.97% |
48,493
+12,094
| +33% | +$452K |
|
|
9
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.79M | 2.93% |
+2,298
| New | +$1.79M |
|
|
10
Amazon
AMZN
$2.44T
| $1.66M | 2.72% |
+2,457
| New | +$1.66M |
|
11
Vulcan Materials
VMC
$38.5B
| $1.62M | 2.66% |
17,096
+1,752
| +11% | +$166K |
|
12
Jazz Pharmaceuticals
JAZZ
$7.75B
| $1.55M | 2.55% |
11,044
+2,908
| +36% | +$409K |
|
|
13
Charles Schwab
SCHW
$174B
| $1.53M | 2.51% |
+46,441
| New | +$1.53M |
|
|
14
Alibaba
BABA
$322B
| $1.43M | 2.35% |
+17,610
| New | +$1.43M |
|
15
Universal Health Services
UHS
$11.6B
| $1.39M | 2.28% |
11,628
+635
| +6% | +$75.9K |
|
16
Heron Therapeutics
HRTX
$207M
| $1.25M | 2.05% |
46,938
-5,009
| -10% | -$134K |
|
|
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.24M | 2.03% |
35,300
-11,979
| -25% | -$419K |
|
|
ALDR
18
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.21M | 1.99% |
36,756
+13,831
| +60% | +$457K |
|
|
AERI
19
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $1.21M | 1.98% |
49,556
-170
| -0.3% | -$4.14K |
|
|
AET
20
DELISTED
Aetna Inc
AET
| $1.2M | 1.96% |
11,075
-2,815
| -20% | -$304K |
|
|
ACOR
21
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $1.2M | 1.96% |
27,932
+5,796
| +26% | +$248K |
|
22
Textron
TXT
$14.3B
| $1.1M | 1.81% |
26,272
+20,373
| +345% | +$856K |
|
|
23
Lam Research
LRCX
$127B
| $1.07M | 1.75% |
+13,442
| New | +$1.07M |
|
24
Synchrony
SYF
$28.4B
| $1M | 1.64% |
+32,910
| New | +$1M |
|
25
Hologic
HOLX
$14.9B
| $986K | 1.62% |
25,488
+578
| +2% | +$22.4K |
|